Barclays Maintains Overweight on MasTec, Lowers Price Target to $55
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Adam Seiden maintains an Overweight rating on MasTec (NYSE:MTZ) but has lowered the price target from $106 to $55.
November 02, 2023 | 3:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays maintains an Overweight rating on MasTec but lowers the price target from $106 to $55, which could impact the stock's performance.
The lowered price target from Barclays could lead to a negative sentiment among investors, potentially causing a short-term decrease in MasTec's stock price. However, the maintained Overweight rating indicates that Barclays still sees potential in the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100